DOdendaal
TL3 Regular · Rouen, FR
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 15 August 2024 · last posted 4d · groups: pharmacists
140 posts, newest first. Showing up to 150.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #118 · Analytics › Home & field testing · 24 Jul 2026 · 0 likes post #117 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Transit times by route, from a logged dataset Replied, post #30 · Sourcing › Logistics · 24 Jul 2026 · 1 like post #29 answers the question as asked. The question underneath it is different. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there…
-
What a certificate commits its issuer to Replied, post #79 · Analytics › COA interpretation · 22 Jul 2026 · 9 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #17 · Clinical › Prescriber conversations · 19 Jul 2026 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #122 · Evidence › Journal club · 19 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Here for the analytics and not much else Replied, post #51 · Lounge › Introductions · 18 Jul 2026 · 10 likes Picking up post #48: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
What a reversed-phase purity number actually is Replied, post #66 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 1 like This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Priming a pen and whether the primed volume is wasted Replied, post #10 · Devices › Pens & autoinjectors · 17 Jul 2026 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #128 · Practice › Reconstitution · 17 Jul 2026 · 7 likes Worth separating two things that post #124 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #20 · Start Here › How to Ask · 13 Jul 2026 · 9 likes Picking up post #17: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Seven-day rolling means and why weekly readings mislead Replied, post #19 · Outcomes › Progress reports · 12 Jul 2026 · 14 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 10 Jul 2026 · 10 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Batch numbers that do not match the vial label Replied, post #40 · Sourcing › Red flags · 8 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Common supplements people ask about, assessed one at a time Replied, post #6 · Practice › Interactions · 3 Jul 2026 · 0 likes Picking up post #3: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
Talking to a therapist about this specifically Replied, post #16 · Wellbeing › Mental health · 27 Jun 2026 · 3 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Alcohol: what is documented and what is folklore Replied, post #72 · Practice › Interactions · 23 Jun 2026 · 0 likes post #71 answers the question as asked. The question underneath it is different. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E,…
-
Coming back to: How much context is too much context in a first post? Replied, post #5 · Start Here › How to Ask · 18 Jun 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
How to disagree with an answer you were given, well Replied, post #11 · Start Here › How to Ask · 18 Jun 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Cost versus information: making the trade-off explicitly Replied, post #3 · Analytics › Home & field testing · 7 Jun 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #42 · Analytics › Home & field testing · 4 Jun 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #20 · Practice › Storage & stability · 2 Jun 2026 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What changed in 2026, by region — does this still hold? Replied, post #11 · Access › International · 27 May 2026 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. Regulatory position dates: a regulatory position is only current as of when it was…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #19 · Analytics › Mass spectrometry · 26 May 2026 · 2 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #91 · Compounds › Tirzepatide · 26 May 2026 · 25 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Does a peptide degrade silently, with no visual change? Replied, post #29 · Practice › Storage & stability · 18 May 2026 · 0 likes Worth separating two things that post #25 runs together. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to…
-
How to ask about something you suspect is a bad idea Replied, post #86 · Start Here › How to Ask · 9 May 2026 · 0 likes post #85 is right about the mechanism and I think understates the practical bit. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #14 · Analytics › Method validation · 6 May 2026 · 4 likes Coming back to post #12, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] What a purity-only report leaves out Replied, post #104 · Sourcing › Independent verification · 25 Apr 2026 · 2 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
The headache that turns out to be dehydration — the long version Replied, post #22 · Nutrition & Training › Hydration & electrolytes · 16 Apr 2026 · 0 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #14 · Pharmacology › Pharmacokinetics · 12 Apr 2026 · 0 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Spike-and-recover accuracy for a peptide assay Replied, post #62 · Analytics › Method validation · 9 Apr 2026 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #27 · Analytics › HPLC & UHPLC · 6 Apr 2026 · 6 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #24 · Evidence › Journal club · 5 Apr 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #55 · Evidence › Trials · 3 Apr 2026 · 22 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Blind submission and why it changes minds — the long version Replied, post #6 · Sourcing › Independent verification · 1 Apr 2026 · 1 like Worth separating two things that post #2 runs together. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for…
-
Spreadsheets: an appreciation — what changed since Replied, post #5 · Lounge › Off topic · 23 Mar 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Five questions in one post gets you one answer — how to split them Replied, post #33 · Start Here › How to Ask · 17 Mar 2026 · 10 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #36 · Sourcing › Vendor reports · 16 Mar 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #4 · Practice › Side effects · 13 Mar 2026 · 1 like Worth separating two things that post #3 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
The lowest dose that does anything: is that a real question? Replied, post #53 · Practice › Dosing & titration · 4 Mar 2026 · 8 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #29 · Compounds › Tirzepatide · 28 Feb 2026 · 22 likes Worth separating two things that post #25 runs together. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Angle of injection and whether 90 degrees is always right Replied, post #103 · Practice › Administration · 20 Feb 2026 · 23 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #81 · Practice › Dosing & titration · 19 Feb 2026 · 13 likes Coming back to post #79, because the follow-up matters more than the original answer. Steady state means the plasma concentration is stable from dose to dose. That…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #49 · Practice › Reconstitution · 19 Feb 2026 · 0 likes Worth separating two things that post #45 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #8 · Analytics › Impurities & related substances · 16 Feb 2026 · 6 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #23 · Evidence › Study critique · 3 Feb 2026 · 21 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: What pooling buys you and what it destroys Replied, post #14 · Evidence › Meta-analyses · 1 Feb 2026 · 7 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #21 · Sourcing › Independent verification · 24 Jan 2026 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #19 · Practice › Interactions · 13 Jan 2026 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #8 · Practice › Side effects · 12 Jan 2026 · 5 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #58 · Regional › UK & Ireland · 11 Jan 2026 · 6 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #47 · Regional › UK & Ireland · 8 Jan 2026 · 8 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Reverse causation in a cohort study of weight and outcome Replied, post #2 · Evidence › Study critique · 25 Dec 2025 · 16 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
Research-use-only labelling: what it means and what it does not Replied, post #76 · Sourcing › Regulatory · 22 Dec 2025 · 0 likes post #75 is right about the mechanism and I think understates the practical bit. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #4 · marked as the solution · Clinical › Comorbidities · 11 Dec 2025 · 11 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #11 · Compounds › Oral incretins · 11 Dec 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #14 · Practice › Interactions · 5 Dec 2025 · 0 likes This follows post #11 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #36 · Practice › Side effects · 27 Nov 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #8 · Compounds › Tirzepatide · 26 Nov 2025 · 3 likes I read post #6 twice before replying, because I had assumed the opposite. Storage and stability: published data on licensed tirzepatide formulations exists and is worth…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #31 · Compounds › Other compounds · 23 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Heterogeneity as information rather than as a nuisance Started this topic · Evidence › Meta-analyses · 14 Nov 2025 · 2 likes Posting this under the heading it deserves: Heterogeneity as information rather than as a nuisance Everything below is what sits behind that. Session topic: SCALE ( N…
-
[2026 update] What steady state means for the decision to escalate Replied, post #23 · Practice › Dosing & titration · 7 Nov 2025 · 8 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #32 · Compounds › Oral incretins · 6 Nov 2025 · 32 likes Coming back to post #30, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Second pass at: Programming during a large energy deficit Replied, post #67 · Nutrition & Training › Resistance training · 4 Nov 2025 · 0 likes This follows post #64 rather than contradicting it. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building…
-
Reconciling a supplier certificate with an independent result Replied, post #22 · Sourcing › Vendor reports · 4 Nov 2025 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #156 · Practice › Reconstitution · 31 Oct 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pooling trials with different estimands — what changed since Replied, post #44 · Evidence › Meta-analyses · 30 Oct 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Sleep tracking data and its considerable limitations Replied, post #70 · Wellbeing › Sleep · 23 Oct 2025 · 0 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Publishing an inconvenient result: a case study — the long version Replied, post #15 · Sourcing › Independent verification · 21 Oct 2025 · 16 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Payment mechanics and the recovery options that do not exist Replied, post #2 · Sourcing › Payments · 18 Oct 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Why appetite effects are mostly central Replied, post #65 · Pharmacology › Receptor biology · 12 Oct 2025 · 3 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #9 · Practice › Storage & stability · 8 Oct 2025 · 15 likes I read post #7 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 2 likes This follows post #23 rather than contradicting it. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its…
-
When a preprint is the best available evidence and we say so Replied, post #132 · Evidence › Preprints · 3 Sep 2025 · 0 likes On post #128 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #23 · Practice › Administration · 17 Aug 2025 · 5 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #40 · Compounds › Semaglutide · 11 Aug 2025 · 0 likes This follows post #37 rather than contradicting it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #6 · Evidence › Journal club · 7 Aug 2025 · 30 likes Worth separating two things that post #2 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #54 · Clinical › Special populations · 5 Aug 2025 · 15 likes post #53 is right about the mechanism and I think understates the practical bit. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating…
-
A ten-fold dose error caught before injection — one year on Replied, post #118 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes I read post #116 twice before replying, because I had assumed the opposite. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the…
-
Thyroid function tests during substantial weight change Replied, post #14 · Clinical › Bloodwork · 26 Jul 2025 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
The C-cell question: rodent findings and their human context Replied, post #43 · Compounds › Semaglutide · 26 Jul 2025 · 15 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Counter-ion content and its effect on measured mass Replied, post #95 · Analytics › Mass spectrometry · 18 Jul 2025 · 21 likes Worth separating two things that post #91 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Substitution between formats during a shortage Replied, post #24 · Access › Shortages · 17 Jul 2025 · 18 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Subcutaneous absorption kinetics and site differences Replied, post #13 · Pharmacology › Pharmacokinetics · 5 Jul 2025 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #74 · Compounds › Retatrutide · 4 Jul 2025 · 0 likes This follows post #71 rather than contradicting it. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the…
-
Interim analyses and stopping rules — does this still hold? Replied, post #22 · Evidence › Trials · 1 Jul 2025 · 1 like Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #72 · Clinical › Comorbidities · 23 Jun 2025 · 11 likes On post #68 — agreed on the reasoning, with one qualification. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #56 · Evidence › Trials · 18 Jun 2025 · 0 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #90 · Practice › Reconstitution · 12 Jun 2025 · 7 likes Worth separating two things that post #86 runs together. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #17 · Practice › Dosing & titration · 9 Jun 2025 · 5 likes I read post #15 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
What a documentation review can and cannot tell you Replied, post #2 · Sourcing › Independent verification · 9 Jun 2025 · 23 likes Worth separating two things that the opening post runs together. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #17 · Evidence › Trials · 6 Jun 2025 · 5 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #14 · Sourcing › Regulatory · 6 Jun 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Coming back to: Getting a referral rather than a refusal Replied, post #31 · Clinical › Prescriber conversations · 4 Jun 2025 · 10 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Follow-up: What other technical communities get right that we do not Replied, post #112 · Lounge › Off topic · 28 May 2025 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #48 · Sourcing › Independent verification · 27 May 2025 · 2 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #5 · Compounds › Semaglutide · 23 May 2025 · 7 likes Worth separating two things that the opening post runs together. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #41 · Evidence › Journal club · 18 May 2025 · 24 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Storing a pen in use versus a pen unopened Replied, post #14 · Devices › Pens & autoinjectors · 16 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #18 · Outcomes › Body composition · 8 May 2025 · 25 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #90 · Sourcing › Red flags · 4 May 2025 · 9 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Ipamorelin selectivity claims and where they came from — a second dataset Replied, post #2 · Compounds › Secretagogues & GH axis · 30 Apr 2025 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A ten-fold dose error caught before injection Replied, post #21 · Devices › Syringes & needles · 15 Apr 2025 · 30 likes I read post #19 twice before replying, because I had assumed the opposite. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are…
-
Retatrutide dose escalation in the published trials Replied, post #117 · Compounds › Retatrutide · 11 Apr 2025 · 0 likes post #116 answers the question as asked. The question underneath it is different. What we do not know about retatrutide, listed explicitly: long-term safety, real-world…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #72 · Wellbeing › Mental health · 8 Apr 2025 · 16 likes Picking up post #69: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
Carryover and the ghost peak from last week's standard Replied, post #33 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 5 likes On post #29 — agreed on the reasoning, with one qualification. Method validation is the demonstration that a method can separate the compound from its degradation…
-
Requesting a page: what makes a good request Replied, post #40 · Documentation › Wiki requests · 31 Mar 2025 · 8 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #102 · Compounds › Semaglutide · 15 Mar 2025 · 10 likes Picking up post #99: that is the part I would want checked first. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #84 · Pharmacology › Receptor biology · 12 Mar 2025 · 11 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #48 · Evidence › Journal club · 27 Feb 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Official shortage notices and what they authorise Replied, post #21 · Access › Shortages · 16 Feb 2025 · 27 likes Coming back to post #19, because the follow-up matters more than the original answer. Patient advocacy during shortages: some advocacy groups advocate for patients…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #59 · Analytics › Mass spectrometry · 16 Feb 2025 · 14 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Reading a chromatogram someone posted without axes Replied, post #3 · Analytics › HPLC & UHPLC · 13 Feb 2025 · 4 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
When "no data" is the complete and final answer Replied, post #76 · Compounds › Other compounds · 26 Jan 2025 · 11 likes Picking up post #73: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #53 · Analytics › COA interpretation · 25 Jan 2025 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #122 · Access › Insurance & coverage · 15 Jan 2025 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Oxidation pathways for methionine and tryptophan Replied, post #14 · Analytics › Impurities & related substances · 26 Dec 2024 · 15 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #70 · Compounds › Semaglutide · 25 Dec 2024 · 4 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Turnaround times and what they mean for a decision — one year on Replied, post #23 · Sourcing › Independent verification · 21 Dec 2024 · 23 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Why mass spectrometry cannot tell you about an epimer Started this topic · Analytics › Mass spectrometry · 7 Dec 2024 · 0 likes Why mass spectrometry cannot tell you about an epimer I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #134 · Compounds › Repair & healing peptides · 24 Nov 2024 · 6 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #51 · Compounds › Tirzepatide · 23 Nov 2024 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #37 · Access › Insurance & coverage · 22 Nov 2024 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #21 · Practice › Reconstitution · 21 Nov 2024 · 13 likes Worth separating two things that post #17 runs together. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection.…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #13 · Nutrition & Training › Protein & intake · 20 Nov 2024 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #103 · Clinical › Prescriber conversations · 19 Nov 2024 · 5 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #2 · Devices › Syringes & needles · 15 Nov 2024 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
When "no data" is the complete and final answer Replied, post #21 · Compounds › Other compounds · 15 Nov 2024 · 17 likes post #20 is right about the mechanism and I think understates the practical bit. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #9 · Wellbeing › Mental health · 18 Oct 2024 · 26 likes This follows post #6 rather than contradicting it. Support and community: some people process weight change through community (online or in-person). Others prefer…
-
Requesting a page: what makes a good request — what changed since Replied, post #46 · Documentation › Wiki requests · 10 Oct 2024 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #96 · Sourcing › Independent verification · 29 Sep 2024 · 28 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #15 · Practice › Side effects · 20 Sep 2024 · 0 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #42 · Evidence › Journal club · 13 Sep 2024 · 9 likes Coming back to post #40, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #42 · Compounds › Semaglutide · 8 Sep 2024 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #8 · Clinical › Bloodwork · 3 Sep 2024 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose…
-
The topic list is dense — is that deliberate? Replied, post #9 · Meta › Site feedback · 30 Jul 2024 · 23 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 22 Jul 2024 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #103 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Cold packs, phase-change material, and what survives ten days Replied, post #87 · Sourcing › Logistics · 9 Jul 2024 · 11 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…